New Wave Holdings Corp. funds Delos Psyche to back LSD research
Category: #health  By Mateen Dalal  Date: 2020-06-06
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

New Wave Holdings Corp. funds Delos Psyche to back LSD research

New Wave Holdings Corp., a Canadian company that focuses on entertainment and esports facilities, has recently announced that it would support the Delos Psyche Research Group in its research on determining the impact of small ingestions of psychedelic or hallucinogenic substances like lysergic acid diethylamide (LSD) for therapeutic or medicinal purposes.

According to reliable sources, the motive behind this observational study is to find few of the impacts of microdosing LSD on patients suffering from anxiety, depression, stress, along with several other clinical constructs.  The study also intends to determine its effect on positive psychological constructs. This research would employ a naturalistic setting as well as a 3-day dosing cycle over a 30-day timeframe.

Speaking on the move, Trumbull Fisher, President, New Wave Holdings, said that the company is pleased to back Delos Psyche in its research and is looking ahead to working with Delos’s team as they commence this new study. This is a significant step forward to introducing psychedelic therapies to those people who really need it and may greatly benefit from it, claims Fisher.

For the record, microdosing is a practice of consuming small, sub-hallucinogenic portions of psychedelic materials like psilocybin, mescaline, or LSD. It has turned out to be a very popular practice, especially for people who are working in the technology sector, where it is usually consumed to increase motivation, focus, creativity, and quality of relationships.

In other news, neuro-pharmaceutical company Mind Medicine recently made a significant stride in the psychedelic sector when it launched its commercial drug development program, Project Lucy. The program intends to find a treatment for anxiety disorders.

Evidently, Mind Medicine is set to start a Phase 2b human efficacy study that would emphasize on experiential doses of LSDs under the supervision of a therapist. This would be the first psychedelic-assisted, experiential therapy to be added to the company’s drug development pipeline.

Source Credit: https://www.prnewswire.com/news-releases/new-wave-holdings-corp-provides-funding-for-lsd-research-study-301071139.html

 

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Mateen Dalal     twitter

Mateen Dalal

A qualified electronics and telecommunication engineer, Mateen Dalal embarked on his professional journey working as a quality and test engineer. Harnessing his passion for content creation however, Mateen pens down industry-rich articles for ReportsGO.com and a few o...

Read More..

More News By Mateen Dalal

General Motors to recoup USD 1.9 Bn from LG spent on Bolt EV recall

General Motors to recoup USD 1.9 Bn from LG spent on Bolt EV recall

By Mateen Dalal

GM will recover almost all the costs from the recall of its Bolt EV models. Despite the EV battery manufacturing mishap from LG, the two companies will continue to work together. General Motors (GM) has agreed to recover around USD 1.9 billion f...

Tata Motors records 25% jump in global sales in second quarter of 2021

Tata Motors records 25% jump in global sales in second quarter of 2021

By Mateen Dalal

The automaker’s annual wholesale growth has been around 24%. The company saw a 10% rise in passenger car sales during Q2 2021, as compared to the same period in 2020. Tata Motors Limited reported substantial growth in Q2 2021, with its glo...

Carbon Budgets for corporate business travels to hit airlines: Report

Carbon Budgets for corporate business travels to hit airlines: Report

By Mateen Dalal

With major companies considering ways to reduce carbon emissions from corporate travel, airlines are preparing for a setback in business-class travel, which is an important revenue driver according to industry experts and executives. The airline ind...